Industry News
Approved Antibody–Drug Conjugates (ADCs)…
Approved ADC drugs list and the ongoing trails with hot ADC targets such as HER2, EGFR, TROP2, FRα, CLDN18.2,, c-Met, Nectin-4.
Lipid-Based Nanoparticles: Liposomes VS. …
Liposomes and Lipid nanoparticles (LNPs) are similar ─ and both can be effective for drug delivery ─ but are different in composition and function.
Lipid Nanoparticles (LNP) for mRNA Drug D…
Lipid Nanoparticle (LNP) is currently the dominant mRNA Drug delivery system.
New FDA Approved Drugs in Q1 2022
With the first three months of 2022 now in the rear-view mirror, the FDA has approved 10 new drugs (Table 1).
Sitagliptin - First In Class DPP4 Inhibit…
Sitagliptin, the first oral DPP-4 inhibitor to be marketed for treating Type 2 Diabetes
What Are PEG Linkers and Their Applicatio…
Learn more detailes about PEG linkers and its applications in pharmaceutical field.
Antibody-Drug Conjugates for Cancer Thera…
Antibody-drug conjugates (ADCs) are a rapidly evolving class of anticancer therapeutics consisting of antibodies attached to potent cytotoxic drugs via chemical linkers.
CDK4/6 Inhibitors for Treatment of Advanc…
There are three CDK4/6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib approved by FDA to treat Advanced Breast Cancer.
sales@huatengusa.com
+86 0731 89916275